Brief: Ironwood And VectivBio Announce Expiration Of Hart-Scott-Rodino Waiting Period For Proposed Acquisition Of VectivBio
16/06/2023 12:12
June 16 (Reuters) - Ironwood Pharmaceuticals Inc
IRWD.O :
* IRONWOOD AND VECTIVBIO ANNOUNCE EXPIRATION OF
HART-SCOTT-RODINO
WAITING PERIOD FOR PROPOSED ACQUISITION OF VECTIVBIO
Source text for Eikon: ID:nBwFk3xQa
Further company coverage: IRWD.O
Recent news on Ironwood Pharmaceuticals
See all newsBrief: Ironwood Pharmaceuticals Appoints Tammi Gaskins As Chief Executive Officer
Ironwood Pharmaceuticals, Inc. reports results for the quarter ended June 30 - Earnings Summary
Ironwood Q2 revenue rises 33%
Brief: Ironwood Pharmaceuticals Repaid In Full $200 Million 1.5% Convertible Senior Notes Due 2026
Brief: FDA Approves Use Of Linzess In Pediatric Patients Aged 2 & Older With Functional Constipation